GlobeVerge
Home / world
WORLD
US regulators approve Moderna flu vaccine
The company's first mRNA-based flu vaccine, mFLUSIVA, has been approved for use in all adults age 50 and older
GlobeSignal
Health Alert
Public health developments like this can directly affect healthcare decisions and guidance.
Expand ▾
More in General
GlobeSignal: A transparent, keyword-based read on this story's tone and stakes—not financial, political or safety advice. The summary above is the original publisher's excerpt, not AI-generated or rewritten by GlobeVerge. Open the original source link before acting on any story.